A Phase II Study of Oral S-1 with Concurrent Radiotherapy for Locally Advanced Pancreatic Cancer
Phase 2
- Conditions
- locally advanced and unresectable pancreatic cancer
- Registration Number
- JPRN-UMIN000004794
- Lead Sponsor
- HIROYUKI SHINCHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Active infection; severe heart disease; interstitial pneumonitis or pulmonary fibrosis; pleural effusion or ascites; active gastroduodenal ulcer; pregnant or nursing women; severe mental disorder; active concomitant malignancy; or other serious medical conditions;mal-absorption syndrome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy
- Secondary Outcome Measures
Name Time Method Toxicity, progression-free survival, and overall survival